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Myoblast fusion is an essential stepduringmus-
cle differentiation. Previous studies inDrosoph-
ila have revealed a signaling pathway that relays
the fusion signal from the plasma membrane to
the actin cytoskeleton. However, the function
for the actin cytoskeleton in myoblast fusion re-
mains unclear. Here we describe the character-
ization of solitary (sltr), a component of themyo-
blast fusion signaling cascade. sltr encodes the
Drosophila ortholog of the mammalian WASP-
interacting protein. Sltr is recruited to sites of
fusion by the fusion-competent cell-specific re-
ceptor Sns and acts as a positive regulator for
actin polymerization at these sites. Electron
microscopy analysis suggests that formation
of F-actin-enriched foci at sites of fusion is in-
volved in the proper targeting and coating of
prefusion vesicles. These studies reveal a sur-
prising cell-type specificity of Sltr-mediated
actin polymerization in myoblast fusion, and
demonstrate that targeted exocytosis of prefu-
sion vesicles is a critical step prior to plasma
membrane fusion.
INTRODUCTION
Cell-cell fusion is critical to the development and physiol-
ogy of multicellular organisms, and is involved in a variety
of biological processes such as fertilization, myogenesis,
placenta development, bone remodeling, immune re-
sponse, tumormetastasis, and aspects of stem cell-medi-
ated tissue regeneration (reviewed by Chen and Olson,
2005). Thus, a mechanistic understanding of this process
is not only important for fundamental biology but may also
provide a basis for its manipulation in therapeutic settings.
Compared to our understanding of intracellular organ-
elle fusion and virus-cell fusion, much less is known about
the underlying mechanisms of cell-cell fusion. Recent
studies in the genetically amenable fruit fly DrosophilaDevehave begun to provide significant insights into this process
(reviewed by Abmayr et al., 2003; Chen and Olson, 2004).
In Drosophila embryos, development of the segmentally
repeated somatic muscles requires fusion between mus-
cle founder cells and fusion-competent myoblasts. While
different subsets of founder cells express different selector
genes, all fusion-competent cells are specified by a single
transcription factor, Lame duck (Lmd)/Myoblast incompe-
tent (Duan et al., 2001; Ruiz-Gomez et al., 2002). During
myoblast fusion, muscle founder cells attract the sur-
rounding fusion-competent cells, which recognize, attach,
and fuse with founder cells to form multinucleated syncy-
tia. Following syncytia formation, the nucleus of the fu-
sion-competent cell adopts the same transcriptional
profile as that of the founder cell with which it has fused.
Myoblast fusion takes place in two phases, with the first
phase yielding bi- or trinucleated muscle precursors, fol-
lowed by a second phase of additional rounds of fusion
that give rise to muscle fibers with distinct sizes (Rau
et al., 2001). At the ultrastructural level, myoblast fusion
involves several characteristic steps (Doberstein et al.,
1997). Upon cell adhesion, paired vesicles with an elec-
tron-dense margin form along the juxtaposed plasma
membranes between founder and fusion-competent cells.
These vesicles then presumably resolve into elongated
electron-dense plaques along the apposing membranes,
followed by the formation of membrane discontinuity (fu-
sion pores), which ultimately leads to the complete fusion
of the two cells. The importance of these intermediate
structures (vesicles, plaques, and pores) in myoblast fu-
sion is highlighted by the observation that various mutants
arrest fusion at different steps along this path (Doberstein
et al., 1997).
Further insights into the molecular mechanisms of myo-
blast fusion came from the elucidation of a signaling cas-
cade from transmembrane receptors to the actin cytoskel-
eton (reviewed by Abmayr et al., 2003; Chen and Olson,
2004). In founder cells, two immunoglobulin (Ig) domain-
containing transmembrane receptors, Dumbfounded
(Duf)/Kirre and Roughest (Rst)/IrreC, are expressed and
play redundant roles during myoblast fusion (Ruiz-Gomez
et al., 2000; Strunkelnberg et al., 2001). Two parallel path-
ways mediate signal transduction from the fusion recep-
tors to the cytoskeleton. First, a founder cell-specificlopmental Cell 12, 571–586, April 2007 ª2007 Elsevier Inc. 571
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and the cytoskeleton-associated protein Myoblast city
(Mbc) (Chen and Olson, 2001; Menon and Chia, 2001;
Rau et al., 2001). Mbc, as its human ortholog DOCK180,
likely functions as a guanine nucleotide exchange factor
(GEF) for the small GTPase Rac (Brugnera et al., 2002;
Erickson et al., 1997). Consistent with this, Drosophila
Rac is essential for myoblast fusion (Hakeda-Suzuki
et al., 2002). A second pathway downstream of the Duf re-
ceptor involves Loner, a different GEF, and its target, the
small GTPase Arf6 (Chen et al., 2003). The Loner-Arf6
module is required for the proper localization of Rac, thus
converging into the Ants/ Mbc/ Rac pathway at the
level of Rac (Chen et al., 2003). Signal transduction in
fusion-competent cells is relatively less characterized.
Two fusion-competent cell-specific receptors, Sticks and
stones (Sns) and Hibris (Hbs), have been identified (Artero
et al., 2001; Bour et al., 2000; Dworak et al., 2001). How-
ever, intracellular proteins thatmediate signal transduction
from membrane receptors to the actin cytoskeleton in
fusion-competent cells have yet to be uncovered.
The Wiskott-Aldrich syndrome protein (WASP) family of
proteins, including WASP, neural-WASP (N-WASP), and
WASP family verprolin homologs (WAVEs) 1–3, are impor-
tant regulators of the actin cytoskeleton (reviewed by Miki
and Takenawa, 2003). In mammalian cells, binding of the
small GTPase Cdc42 activates WASPs by releasing
them from an autoinhibitory conformation. WAVEs, on
the other hand, are activated by Rac, another Rho family
small GTPase. Both WASPs and WAVEs feed into the
Arp2/3 complex, a direct regulator of actin polymerization
(reviewed by Stradal and Scita, 2006). Previous studies in
Drosophila have implicated the Mbc / Rac / WAVE
pathway in myoblast fusion, as mutations in mbc, rac, or
the WAVE-associated protein Kette result in myoblast fu-
sion defects (Hakeda-Suzuki et al., 2002; Rushton et al.,
1995; Schroter et al., 2004). However, the precise role of
the actin cytoskeleton in myoblast fusion remains myste-
rious. Specifically, how could organization of the intracel-
lular actin cytoskeleton affect plasma membrane dynam-
ics and fusion?
In this paper, we describe the characterization of a com-
ponent of the myoblast fusion signaling cascade. This
component, which we named Solitary (Sltr), is the Dro-
sophila ortholog of the human WASP-interacting protein
(WIP). We show that Sltr is a fusion-competent cell-
specific protein that is recruited to sites of fusion by the
transmembrane receptor Sns. Sltr is a positive regulator
of actin polymerization and is required for F-actin accumu-
lation at sites of fusion. Electron microscopy analysis sug-
gests that the actin cytoskeleton is involved in targeted
exocytosis of prefusion vesicles at sites of fusion, thus
revealing a critical step prior to plasmamembranemerger.
RESULTS
Myoblast Fusion Defect in sltr Mutant
The solitary (sltr) allele S1946 was isolated in a genetic
screen for fusion-defective mutants. Homozygous sltr572 Developmental Cell 12, 571–586, April 2007 ª2007 Elseviemutant embryos contain many mononucleated myosin
heavy chain (MHC)-positive myocytes (Figures 1A and
1B). This lack-of-fusion phenotype is further confirmed
by electron microscopy, which reveals myoblast clusters
containing single founder cells surrounded by multiple un-
fused competent cells (see Figure S1 in the Supplemental
Data available with this article online). Dmef2, whichmarks
the nuclei of all somatic muscle cells (Lilly et al., 1994;
Nguyen et al., 1994), is similarly expressed in wild-type
and sltr embryos, suggesting that muscle cell fate is prop-
erly specified in sltr embryos (Figures 1H and 1I). Thus, the
fusion phenotype of sltr embryos does not result from
a secondary consequence of defective muscle cell fate
determination. In late-stage embryos, unfused myoblasts
are seen attached to elongated muscle precursors (Fig-
ures 1D and 1E), suggesting that the sltr mutation does
not affect the recognition or adhesion between founder
and fusion-competent cells, but blocks a later step in
myoblast fusion.
Myoblast fusion takes place in two phases, with the first
phase yielding bi- or trinucleated muscle precursors, fol-
lowed by a second phase of additional rounds of fusion
that give rise to muscle fibers with distinct sizes (Rau
et al., 2001). To determine which phase of fusion is de-
fective in sltr embryos, we examined the expression of
two transcription factors, Kru¨ppel (Kr) and Even skipped
(Eve), which mark different subsets of muscle founder
cells (Carmena et al., 1998; Ruiz-Gomez and Bate,
1997). In wild-type embryos, Kr staining is initially de-
tected in bi- or trinucleated muscle precursors at stage
13 (Figure 1J), evolves into multinucleated clusters at
stage 14 (Figure 1L), and is absent from mature muscle fi-
bers (Ruiz-Gomez and Bate, 1997). The characteristic pat-
tern of Kr expression remains the same in sltr mutant
embryos, except that each Kr-positive ‘‘cluster’’ is mono-
nucleated at stage 13 (Figure 1K) but contains one to three
nuclei at stage 14 (Figure 1M). These results suggest that
the fate of Kr-positive founder cells is properly specified at
stage 13, although these cells complete the first phase of
fusion to form bi- or trinucleated syncytia at a later stage
compared to wild-type. Similar results were obtained with
Eve-positive founder cells. While stage 14 Eve-positive
dorsal acute muscle 1 (DA1) contains approximately ten
nuclei in each cluster (Figure 1F), its counterpart in sltr
mutant embryos is mostly binucleated (Figure 1G). We
conclude that sltr is required for the second phase of
fusion to form multinucleated syncytia.
Due to its low resolution, direct visualization of myo-
blasts with MHC antibody (Figures 1B–1E) cannot unam-
biguously exclude the possibility that small fusion pores
might have formed between the founder cells and the sur-
rounding fusion-competent cells in sltr mutant embryos.
We devised a green fluorescent protein (GFP) diffusion
assay to directly test this possibility. When GFP was ex-
pressed in sltr mutant embryos via the founder cell-
specific rP298-GAL4 driver, we found that the GFP signal
was completely retained within the Kr-positive founder
cells (Figures 1N–1N00). Given the small size of GFP (a b-
barrel structure with a diameter of 3.2 nm and a lengthr Inc.
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(A–C)Wild-type ([A]; stage 14), sltrS1946 ([B]; stage 13), and sltrS1946/Df(2R)X58-7 ([C]; stage 13) embryos stained for myosin heavy chain (MHC; green).
Note the presence of numerous mononucleated myoblasts in sltr mutants (compare [B] and [C] with [A]).
(D and E) Stage 14 sltr embryos stained for MHC (green) and Ants (red). (E) shows the boxed area in (D). Note that mononucleated fusion-competent
cells extend filopodia and attach to elongated muscle precursors at sites where Ants is accumulated.
(F and G) Stage 14 embryos stained for Eve (green) and Titin (red). The Eve-positive DA1 cluster has an average of 9.9 ± 0.1 (n = 35) and 1.78 ± 0.1 (n =
39) nuclei in wild-type (F) and sltr (G) embryos, respectively.
(H and I) Stage 13 embryos stained for Dmef2 showing a similar number of Dmef2-positive nuclei in wild-type (H) and sltr (I) embryos.
(J and K) Stage 13 embryos stained for Kr, showing three lateral clusters (circled) containing an average of 2.6 ± 0.1 (n = 29) (LL1), 2.3 ± 0.2 (n = 28)
(LT2), and 2.1 ± 0.2 (n = 27) (LT4) nuclei in wild-type (J), but single nucleus in sltr mutant (K).
(L and M) Stage 14 embryos showing three lateral clusters (circled) containing 3.6 ± 0.1 (n = 30) (LL1), 2.7 ± 0.1 (n = 29) (LT2), and 2.9 ± 0.2 (n = 26)
(LT4) Kr-positive nuclei in wild-type (L), but mono- or binucleated clusters (arrows) in sltrmutant (M). The average numbers of Kr-positive nuclei in sltr
embryos are 1.4 ± 0.1 (n = 36) (LL1), 1.5 ± 0.1 (n = 33) (LT2), and 1.4 ± 0.1 (n = 34) (LT4).
(N–N00) Complete block of fusion in sltr embryos. An rP298-GAL4; sltrS1946/sltrS1946, UAS-GFP embryo (stage 14) labeled with a-GFP (green) and a-Kr
(red). Two Kr-positive precursors are shown, one of which is binucleated. Note that the GFP signal (cytoplasmic) closely matches the Kr signal
(nuclear), without diffusing into adjacent fusion-competent cells.
(O) Genomic structure of the sltr gene. The exons encoding Sltr Iso1 are shown in black, the additional exon in Iso2 is in green, and exon 8 in Iso3 is in
red. Arrowheads mark translational start and stop sites. The blue bracket indicates DNA deleted in sltrS1946.
(P) Schematic of the isoforms of Sltr and Sltr homologs in yeast, mouse, and human. Iso1 and Iso2 are present in the embryo (see Figure S2). Amino
acid identity between Sltr and its human homolog is shown.
(Q) Alignment of the WH2 core domains. Note the conservation of the Sltr WH2-1 domain, and the R/ G and a K/ P change in the Sltr WH2-2
domain.Developmental Cell 12, 571–586, April 2007 ª2007 Elsevier Inc. 573
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presence of any membrane openings with a diameter of
R3.2 nm between the founder and the fusion-competent
cells in sltr mutant embryos.
Molecular Characterization of sltr
We performed a complementation test between sltr and a
collection of deficiencies on the second chromosome. sltr
failed to complement Df(2R)X58-7, which deletes the re-
gion between 58B1-2 and 58E1-4. Transheterozygotes
of sltr over this deficiency (sltrS1946/Df(2R)X58-7) show
similar phenotype as sltrS1946 homozygous embryos
(Figure 1C), with muscle DA1 in these embryos containing
1.7 ± 0.2 (n = 24) Eve-positive nuclei. Thus, sltrS1946 be-
haves as a null allele. We further mapped sltr to 58B1-
C1, as it failed to complement a smaller deficiency
Df(2R)Exel7170, which deletes approximately 20 genes
between CG10138 and CG13504. We sequenced candi-
date genes in this interval and found that one of them,
CG13503, contained a deletion in the genomic DNA of
sltr mutant embryos (Figure 1O). We therefore renamed
CG13503 as sltr.
The sltr locus spans 15 kb and is predicted to generate
six differentially spliced mRNAs (RA to RF) (BDGP;
Figure 1O; Figure S2A). RT-PCR analyses revealed three
differentially spliced transcripts in embryos encoding
a 708 amino acid (Iso1) and a 718 amino acid (Iso2) variant
(Figure 1P; Figure S2). Notably, the predicted exon 8 (E8)
is absent from the embryonic transcripts. Database
searches revealed that Sltr represents the sole Drosophila
homolog of the yeast very proline-rich protein (verprolin)
and human WASP-interacting protein (WIP) (Figure 1P).
Yeast verprolin and mammalian WIP are important reg-
ulators of the actin cytoskeleton (reviewed by Anton and
Jones, 2006). In mammalian cells, WIP forms a stable
complex with WASP, which in turn regulates actin poly-
merization via the Arp2/3 complex. The importance of
the WIP-WASP interaction is highlighted by the fact that
the majority of Wiskott-Aldrich patients carry missense
mutations in the WH1 domain of WASP, a domain which
is required for WIP binding (Volkman et al., 2002). Despite
its broad expression (Ramesh et al., 1997), WIP-deficient
mice appear largely normal, with the exception of defec-
tive T cell activation due to subcortical actin-filament de-
fects (Anton et al., 2002). The subtlety of theWIP knockout
phenotype could be partly explained by the existence of
additional WIP-related proteins in mammals such as
WIRE/WICH and CR16 (reviewed by Anton and Jones,
2006). The presence of a single WIP-like protein in Dro-
sophila should overcome the difficulties in studying poten-
tially redundant WIPs in mammals.
Sltr contains two WASP homology 2 (WH2) domains,
a proline-rich region and a WASP-binding domain (WBD)
(Ramesh et al., 1997; Paunola et al., 2002). The WH2 do-
main has been shown to bind to monomeric actin through
an amphiphilic a helix and an LKKT motif (Chereau et al.,
2005). While the core region of the first WH2 domain in
Sltr (amino acids 34–51) contains all the critical residues
required for actin binding, that of the secondWH2 domain574 Developmental Cell 12, 571–586, April 2007 ª2007 Elsevie(amino acids 101–122) has a K/ P change in the highly
conserved LKKT motif as well as an R / G change in
the amphiphilic a helix (Figure 1Q). These amino acid sub-
stitutions abolish the binding of the second WH2 domain
to G-actin (see below). The sltrS1946 allele deletes 1.2 kb
genomic DNA spanning three exons that encode part
of the proline-rich region (Figure 1O), resulting in a trun-
cated protein of 325 amino acids (numbering according
to Iso1).
Sltr Is Specifically Expressed in Fusion-Competent
Myoblasts
As a starting point to characterize Sltr function, we exam-
ined the expression of sltr mRNA in Drosophila embryos.
In contrast to the widespread expression of WIP in mam-
mals, sltr is expressed specifically in the developing mus-
culature (Figures 2A–2C). sltrmRNA is first detected in the
visceral and somatic muscles at stage 11 when myoblast
fusion is initiated (Figure 2A), persists in the somatic mus-
cle cells until the end of stage 14when fusion is completed
(Figures 2B and 2C), and disappears from the mature
muscle fibers thereafter (data not shown). Antibody stain-
ing showed that the Sltr protein is expressed in a similar
pattern (Figures 2D–2F).
In order to determine in which myoblast population Sltr
is expressed, we compared the localization of Sltr with
that of Ants, which marks the cytoplasm of founder cells,
andDmef2, whichmarks the nuclei of both founder and fu-
sion-competent cells. As shown in Figure 2G, Sltr is de-
tected in the cytoplasm surrounding the nuclei of fusion-
competent cells. The expression of Sltr and Ants appears
to be exclusive of each other, suggesting that Sltr might be
specifically present in fusion-competent cells. To test this
possibility further, we marked the founder cell membrane
using rP298-GAL4; UAS-CD8GFP and examined the rela-
tive expression of GFP and Sltr. As shown in Figure 2H,
Sltr expression is excluded from the GFP-labeled founder
cells, suggesting that Sltr is exclusively expressed in fu-
sion-competent cells. Definitive proof for this conclusion
was obtained by examining the expression of Sltr in lmd
mutant embryos, which lack all fusion-competent cells.
As shown in Figures 2J and 2J00 0, Sltr expression is absent
in the somatic musculature in the lmd mutant embryo.
Thus, we conclude that Sltr is specifically expressed in
fusion-competent cells. We noticed that Sltr is present in
multinucleated myotubes in late-stage embryos (Figures
2I and 2I0), presumably due to diffusion of the Sltr protein
from fusion-competent cells to fused myotubes.
Sltr Is Localized to Sites of Fusion
Careful examination revealed a nonuniform subcellular lo-
calization of the Sltr protein in the cytoplasm of fusion-
competent cells. Notably, specific foci with strong Sltr ex-
pression are detected (Figures 2K and 2L). These foci are
reminiscent of those reported for other proteins required
for fusion. Indeed, the Sltr-positive foci colocalize with
the fusion receptor, Sns, and the structural protein, Titin,
both of which are known to aggregate to sites of fusion
(Figures 2K–2K00 0). Furthermore, the localization of Sltr tor Inc.
Developmental Cell
Function of Actin Cytoskeleton in Myoblast FusionFigure 2. Expression and Subcellular
Localization of the Sltr Protein at Sites
of Fusion in Fusion-Competent Cells
(A–C) sltr mRNA expression revealed by in situ
hybridization.
(D–F) Sltr protein expression stained by a-Sltr
antibody.
(G) Awild-type stage 13 embryo labeled with a-
Sltr (green), a-Ants (red), and a-Dmef2 (blue).
Note the close association of the Sltr signal
with fusion-competent cells (blue nuclei), but
not with the founder cell (red).
(H) A stage 13 rP298-GAL4; UAS-CD8GFP em-
bryo double labeledwith a-Sltr (red) and a-GFP
(green). Note the mutual exclusion of the Sltr
signal with that of the founder cell-specific
GFP signal.
(I and I0) A stage 14 embryo showing the pres-
ence of Sltr (green) in fused myotubes marked
by a-Ants (red) (arrow). Note that there is still
high-level Sltr in discrete foci (arrowhead).
(J–J00 0) Stage 13 embryos produced by lmd/
TM3, ftz-lacZ parents were labeled with a-Sltr
(green), a-b-gal (blue), and a-Ants (red). The
control (right) and mutant (left) lmd embryos
can be unambiguously identified based on
the absence of b-gal signal in the homozygous
lmd embryo. Note that Ants, but not Sltr, is
present in the lmd mutant embryo.
(K–K00 0 ) Localization of Sltr to sites of fusion. A
wild-type embryo labeled with a-Sltr (green),
a-Titin (blue), and a-Sns (red). Note the coloc-
alization of the Sltr-positive foci with those of
Titin and Sns (appearing as white spots in the
merged image).
(L–O) Wild-type (L), sns (M), mbc (N), and
rac1rac2 (O) embryos labeled by a-Sltr. Sltr-
positive foci are present in wild-type,mbc, and
rac1rac2 embryos, but absent in sns embryos.sites of fusion is dependent on the fusion receptor Sns, as
Sltr protein is evenly distributed in the cytoplasm of fusion-
competent cells in sns mutant embryos (Figure 2M). This
change in Sltr subcellular localization is not simply due
to lack of fusion, as Sltr-positive foci are still present in
other fusion mutants such as mbc or rac1rac2 (Figures
2N and 2O). These results also indicate that the recruit-
ment of Sltr to the fusion receptor Sns is independent of
the Mbc/ Rac/ WAVE pathway.
Sltr Is an Actin- and WASP-Binding Protein
The presence of WH2 and WBD domains in Sltr suggests
that Sltr may interact with G-actin and WASP. A GST fu-
sion protein containing an N-terminal fragment of Sltr
with two WH2 domains (N) was found to bind monomeric
G-actin (Figures 3A and 3B). Interestingly, a point mutation
of a conserved lysine within the first WH2 domain (N-
K49Q), a deletion of the first WH2 domain (N-DWH2-1),
or deletion of both WH2 domains (N-DWH2-1&2), all abol-
ished the G-actin-binding activity, whereas deleting the
secondWH2 domain (N-DWH2-2) did not affect this activ-
ity (Figure 3B). Thus, the first, but not the second,WH2 do-
main of Sltr binds to G-actin. These results are consistentDevelowith the high degree of conservation of the first, but not the
second, WH2 domain of Sltr (Figure 1Q).
Previous studies have shown that the mammalian ho-
mologs of Sltr (WIP, WICH/WIRE, and CR16) associate
with F-actin as well as G-actin (reviewed by Anton and
Jones, 2006). We therefore tested whether Sltr binds to
F-actin by cosedimentation assays. As shown in Fig-
ure 3C, the N-terminal fragment of Sltr (N) binds to F-actin,
which is consistent with previous studies mapping the F-
actin-binding site to the N-terminal region of human WIP
(Martinez-Quiles et al., 2001). We further tested which
sequence(s) within N binds F-actin. Interestingly, deleting
the first WH2 domain (N-DWH2-1) did not affect F-actin
binding, whereas deleting the second WH2 domain (N-
DWH2-2) impaired the ability of N to bind F-actin
(Figure 1C). These results demonstrate that while G-actin
binds to the first WH2 domain, F-actin interacts prefer-
entially with the second WH2 domain and its flanking
sequences. Thus, G-actin and F-actin bind to different
regions in Sltr.
We performed coimmunoprecipitation (co-IP) assays to
detect potential interactions between Sltr and WASP. As
shown in Figure 3D, a Flag-tagged Sltr coprecipitatedpmental Cell 12, 571–586, April 2007 ª2007 Elsevier Inc. 575
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(A) Schematic diagram of Sltr, as well as the point mutation and N- and C-terminal fragments used in these binding assays.
(B) GST pull-down assay showing that the first (WH2-1), but not the second (WH2-2), WH2 domain of Sltr binds G-actin.
(C) F-actin cosedimentation assay showing that WH2-2 is involved in F-actin binding.
(D) Extracts fromS2R+ cell transfectedwith the indicated plasmidswere immunoprecipitated (IP) and probed (IB) with the indicated antibodies, show-
ing specific association between Sltr and WASP.
(E) WASP-V5 expressed in S2R+ cells was incubated with the indicated GST fusion proteins in a GST pull-down assay.
(F) GST-Crk was incubated with S2R+ extracts expressing the indicated epitope-tagged proteins. Note that GST-Crk can pull downWASP-V5 only in
the presence of Flag-Sltr.
(G) Co-IP of Crk-V5 with Flag-Sltr expressed in S2R+ cells.
(H) Co-IP of Crk-V5 with Sns expressed in S2R+ cells.with a V5-tagged WASP expressed in Drosophila S2R+
cells. GST pull-down assays were carried out to map the
WASP-binding domain within Sltr. A C-terminal fragment
encompassing the predicted WBD, but not the N-terminal
region, efficiently pulled down the V5-tagged WASP
(Figure 3E). Further mapping of the C-terminal region re-
vealed that a smaller fragment containing merely the
WBD (C2), but not a fragment without the WBD (C1),
pulled down WASP-V5 (Figure 3E), demonstrating that
Sltr interacts with WASP through its WBD domain.576 Developmental Cell 12, 571–586, April 2007 ª2007 ElsevieThe Small Adaptor Protein Crk Provides a Potential
Link between Sltr and the Fusion Receptor Sns
The presence of a proline-rich region suggests that Sltr
may interact with SH3 domain-containing proteins. A rel-
evant candidate in myoblast fusion is the SH2 and SH3
domain-containing adaptor protein Crk. While a loss-of-
function mutant for Drosophila Crk is not available, over-
expression of a membrane-targeted form of Crk is known
to cause a myoblast fusion defect (Abmayr et al., 2003).
GST pull-down and co-IP assays were performed to testr Inc.
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Figure 3F, GST-Crk was able to pull down Flag-tagged
Sltr expressed in S2R+ cells. In addition, V5-tagged Crk
coimmunoprecipitated with Flag-tagged Sltr in S2R+ cells
(Figure 3G), further supporting a physical association
between these two proteins.
It is formally possible that the interaction between Sltr
and Crk is mediated by WASP, as WASP also contains
a proline-rich domain (reviewed by Miki and Takenawa,
2003) and it forms a tight complex with Sltr (this study).
However, GST-Crk could not pull down WASP-V5 ex-
pressed alone in S2R+ cells (Figure 3F), arguing against
a direct interaction between Crk and WASP. Interestingly,
GST-Crk effectively pulled downWASP-V5when Flag-Sltr
was coexpressed, consistent with the idea that Sltr medi-
ates the formation of the Crk-Sltr-WASP complex.
Because SH2 and SH3 domain-containing proteins are
known tomediate interactions betweenmembrane recep-
tors and downstream effectors, we tested whether Crk
may interact with the fusion-competent cell receptor
Sns. As shown in Figure 3H, a co-IP assay revealed a spe-
cific interaction between Sns and V5-tagged Crk in S2R+
cells. Taken together, these results suggest that Crk may
be the adaptor protein that recruits Sltr to sites of fusion
defined by Sns in vivo.
Sltr Induces Actin Polymerization by Interacting
with Actin and WASP
Studies of mammalian WIP have thus far provided con-
flicting evidence onWIP’s function in actin polymerization.
While biochemical analysis suggested an inhibitory role for
WIP in actin polymerization (Martinez-Quiles et al., 2001),
cell culture studies showed that WIP promotes the forma-
tion of actin-rich filopodia (Martinez-Quiles et al., 2001;
Ramesh et al., 1997). We took advantage of Drosophila
S2 cells to investigate Sltr’s role in actin polymerization.
Overexpressing Sltr in S2 cells resulted in a dramatic in-
crease in F-actin, leading to the formation of numerous
actin-filled microspikes, a phenotype observed in 100%
of the transfected cells (compare Figures 4Aa–4Aa00 and
Figures 4Ab–4Ab00). Deletion of the first WH2 domain
(SltrDWH2-1) or a point mutation of a conserved lysine in
WH2-1 (SltrK49Q) significantly reduced F-actin-inducing
activity, suggesting that G-actin binding is required for
Sltr to promote actin polymerization (Figures 4Ac–4Ad00).
Interestingly, deleting the second WH2 domain
(SltrDWH2-2) also reduced the number of microspikes
but to a less extent compared to SltrDWH2-1 (Figures
4Ae–4Ae00). Not surprisingly, when both WH2 domains
are deleted, microspike formation was abolished (Figures
4Af–4Af00). The F-actin-inducing activity of Sltr also re-
quires WASP, as deletion of the WBD (SltrDWBD), or
a knockdown of endogenous WASP through RNAi, abol-
ished this activity (Figures 4Ag–4Ah00). Taken together,
we conclude that Sltr positively regulates actin polymeri-
zation by interacting with G-actin, F-actin, and WASP.
The functional importance of the WH2 and WBD do-
mains was further tested by in vivo rescue assays. Full-
length Sltr rescued the myoblast fusion defect in sltr mu-Devetant embryos (Figures 4Bi and 4Bj). However, mutations
that remove one or both WH2 domains, that change a crit-
ical residue (K49Q) in the first WH2 domain, or that delete
theWBD, all failed to rescue the fusion phenotype, despite
the proper localization of mutant proteins to cell contact
sites (Figures 4Bk–4Bo; Figure S3). Thus, the same do-
mains that affect actin polymerization are equally impor-
tant for myoblast fusion in vivo.
WASP Is Required for Myoblast Fusion
The importance of the WBD for Sltr’s function in myoblast
fusion suggests that WASP may also be required for this
process. Drosophila has a single WASP homolog, Wasp,
which has been shown to function in asymmetric cell divi-
sion during embryogenesis (Ben-Yaacov et al., 2001).
However, its potential function in muscle development
has not been reported. To examine Wasp’s function dur-
ing myogenesis, we generated germline clones of Wasp
(Waspmat/zyg) which eliminate both maternal and zygotic
expression of the gene. As shown in Figure 4Bp,
Waspmat/zyg embryos exhibit a severe loss-of-fusion phe-
notype, similar to that of sltrmutant embryos, further sup-
porting our model that Sltr functions through WASP to
regulate myoblast fusion.
Sltr Is Required for Localized Induction of Actin
Polymerization at Sites of Fusion
The effect of Sltr on actin polymerization in S2 cells and
the requirement of its WH2 and WBD domains in vivo
strongly indicate a role for Sltr in regulating actin polymer-
ization duringmyoblast fusion. To investigate this possibil-
ity, we visualized F-actin in stage 13 embryos by phalloidin
staining. Interestingly, F-actin-rich foci are observed co-
localizing with those of Sltr and Titin at sites of fusion (Fig-
ures 5A–5A00 and 5B–5B00). Like Sltr, formation of the F-
actin foci requires the fusion receptor Sns, as they are
absent in sns mutant embryos (Figures 5C–5C00). Careful
analyses of pairs of adjacent founder/myotube and fu-
sion-competent cells revealed that F-actin is enriched at
cell contact sites between these two types of cells and
that a larger portion of a given F-actin focus colocalizes
with Sltr residing in fusion-competent cells, whereas a
smaller portion of the same focus colocalizes with Ants
in founder cells (Figures 5D–5F00 0). Given the function of
Sltr in promoting actin polymerization in cultured cells, co-
localization between Sltr and F-actin indicates that Sltr
may be involved in inducing actin polymerization at sites
of fusion. Indeed, F-actin foci are greatly diminished in
fusion-competent cells in sltr mutant embryos, whereas
F-actin gradually accumulates to an abnormally high level
in the adjacent founder cell along the apposing mem-
branes (Figures 5G–5I00 0). Taken together, Sltr is required
for receptor-triggered induction of actin polymerization
at sites of fusion in fusion-competent cells.
Sltr Is Required for Targeted Exocytosis
of Prefusion Vesicles to the Plasma Membrane
The presence of F-actin foci at sites of fusion and their ab-
errant behavior in sltr mutants strongly suggest that actinlopmental Cell 12, 571–586, April 2007 ª2007 Elsevier Inc. 577
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Function of Actin Cytoskeleton in Myoblast FusionFigure 4. Sltr Promotes Actin Polymerization and the Requirement of WH2 and WBD Domains for Sltr Function In Vivo
(A) S2 cells expressing V5-taggedwild-type and the indicatedmutant Sltr proteins or dsRNAwere stained for F-actin (phalloidin, red) and a-V5 (green).
(B) (i–o) Wild-type and sltr embryos expressing the indicated transgenes were labeled by a-MHC. The fusion defect was rescued by the wild-type
transgene (j), but not any of the mutant transgenes (k–o). (p) The lack-of-fusion defect of a Wasp germline clone (Waspmat/zyg) embryo.cytoskeleton rearrangement plays an important role dur-
ing myoblast fusion. To investigate the precise function
of the actin cytoskeleton during fusion, we performed
electron microscopy (EM) analysis. We focused on the
ventral group of muscles, which have been best charac-
terized by EM (Doberstein et al., 1997). In wild-type em-
bryos, paired vesicles (40 nm in diameter) with elec-
tron-dense margins form at the contact sites between
founder and fusion-competent cells (Doberstein et al.,
1997; Figures 6A–6A00). However, the origin and function
of these vesicles are not known. In wild-type myoblasts,
we observed electron-dense vesicles (40 nm in diame-
ter) in the vicinity of the Golgi, as well as in the process
of budding off from the Golgi (Figures 6E–6E00), indicating578 Developmental Cell 12, 571–586, April 2007 ª2007 Elsevierthat these vesicles are of exocytic origin. We also ob-
served a frequent association of these vesicles with mi-
crotubules (Figures 6F–6F00), suggesting that they are
transported to the cell periphery via the microtubule
network.
In sltrmutantmyoblasts, while we also observed a close
association between the vesicles and themicrotubule net-
work (Figures S4A–S4B0), these vesicles have a profound
defect in membrane targeting. Specifically, paired vesi-
cles are found not only at sites of fusion between the ap-
posing founder and fusion-competent cells but also
between neighboring fusion-competent cells (Figures
6C–6C00). The absence of actin-rich foci (Figures 5G–5I00 0)
and the ectopic routing of vesicles to the plasmaInc.
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Function of Actin Cytoskeleton in Myoblast FusionFigure 5. Sltr Colocalizes with F-Actin Foci and Is Required for Localized Actin Polymerization at Sites of Fusion in Fusion-
Competent Cells
In all panels, F-actin is labeled by FITC-conjugated phalloidin (green).
(A–A00) Sltr (red) colocalizes with F-actin foci in a wild-type embryo.
(B–B00) F-actin foci colocalize with Titin (red) in a wild-type embryo.
(C–C00) Absence of F-actin foci in an sns mutant embryo. Note the presence of Ants foci (red) in the founder cells.
(D–D00 0) An F-actin focus at a cell contact site between fusing myoblasts. Sltr (blue) colocalizes with a larger portion of the actin focus in the fusion-
competent cell, whereas Ants (red) colocalizes with a smaller portion of the actin focus in the founder cell.
(E–I00 0) F-actin at cell contact sites in wild-type (E–F00 0) and sltrmutant (G–I00 0) embryos. Founder cells are labeled by a-Ants (red) and fusion-competent
cells by a-Lmd (blue). In the schematics (E00 0, F00 0, G00 0, H00 0, and I00 0), F stands for founder cell and C stands for fusion-competent cell.
(E–F00 0) Two examples of F-actin foci at sites of fusion between founder and fusion-competent cells in stage 13 wild-type embryos. Note that F-actin is
enriched on both sides of the apposed membranes, although the F-actin foci appear to be larger in fusion-competent cells.
(G–G00 0) F-actin distribution in a stage 13 sltrmutant embryo. Note that the amount of F-actin is greatly diminished in the fusion-competent cells and
starts to accumulate in the founder cell.
(H–I00 0) Two examples of F-actin phenotype in stage 14 sltrmutant embryos. F-actin is nearly absent from fusion-competent cells, but accumulates as
elongated patches in the founder cells along the cell-cell contact sites.membrane in sltr mutant fusion-competent cells suggest
that localized actin polymerization at sites of fusion may
normally provide a positional cue for vesicle transport.
To further corroborate thismodel, we visualized the spatial
relationship between the actin-rich foci and exocytic ves-Develoicles in myoblasts using immuno-EM. This analysis re-
vealed a high concentration of actin adjacent to myoblast
contact sites (Figures 6G and 6G0; Figures S4C–S4D0),
which likely correspond to the actin-rich foci observed
using fluorescent microscopy (Figure 5). Two differentpmental Cell 12, 571–586, April 2007 ª2007 Elsevier Inc. 579
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Function of Actin Cytoskeleton in Myoblast FusionFigure 6. Sltr and Actin-Rich Foci Are Involved in Vesicle Targeting and Coating
Conventional electronmicroscopy (A–F00) and immuno-EM (G–H00) micrographs of wild-type and sltrmutant embryos. Schematic drawings for (A), (C),
(E), (F), (G), and (H) are shown in (A0 ), (C0), (E0), (F0), (G0 ), and (H0), respectively. Boxed areas in (A), (C), (E), (F), (G), and (H) are enlarged in (A00), (C00), (E00),
(F00), (G00/G00 0), and (H00), respectively.
(A–A00) Vesicles (40 nm diameter) with an electron-dense margin are present between founder and fusion-competent cells at early stage 13 in a wild-
type embryo. The founder cell, labeled F, is inferred by its relative position in a cluster of myoblasts. The arrow points to vesicles with electron-dense
margins; n, myoblast nuclei.
(B) Fusion pores (arrowheads) in a stage 13 wild-type embryo.
(C–C00) In an early stage 14 sltrmutant embryo, prefusion vesicles are present not only between founder and fusion-competent cells (arrows) but also
along the membranes of adjacent fusion-competent cells (arrowheads).
(D) Accumulation of prefusion vesicles in a stage 14 sltr mutant embryo.
(E–F00) Intracellular localization of prefusion vesicles in early stage 13 embryos.
(E–E00) Prefusion vesicles are observed budding off from the Golgi (arrow), or in the vicinity of the Golgi (arrowhead).580 Developmental Cell 12, 571–586, April 2007 ª2007 Elsevier Inc.
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Function of Actin Cytoskeleton in Myoblast Fusionclasses of vesicles are also evident (Figures 6G00, 6G00 0,
and 6H00). The first class of vesicles are ‘‘actin coated,’’
which are present either within the actin-rich patches or
as paired vesicles aligned at the plasma membrane (Fig-
ures 6G00 and 6H00; Figures S4C–S4D0). The second class
of vesicles, which reside outside of the actin foci, are de-
void of a-actin staining (Figure 6G00 0). We infer that the for-
mer class of vesicles acquires actin coating when they
transit through the actin foci en route to the plasma mem-
brane. Interestingly, actin-rich patches are observed at
the cell cortex only in ‘‘immature’’ myoblasts containing
vesicles in their cytoplasm (Figures 6G and 6G0; Figures
S4C–S4D0), but not in ‘‘mature’’ myoblasts in which vesi-
cles have already paired along the plasma membrane,
suggesting that these actin-rich patches are transient
structures that disintegrate once vesicles have reached
the plasma membrane.
Besides the mistargeting phenotype, the exocytic vesi-
cles also persist much longer in sltr mutant myoblasts. In
wild-type embryos, once vesicles reach sites of fusion,
they rapidly resolve into electron-dense plaques followed
by the formation of fusion pores between the aligned
membranes (Doberstein et al., 1997; Figure 6B). As a re-
sult, fusion of wild-type myoblasts occurs quickly and
is completed in the ventral group of muscles at stage 13
(Doberstein et al., 1997). In sltrmutant embryos, although
vesicles start to appear by the end of stage 13 as in the
wild-type, they never resolve. Instead, the vesicles are still
present in stage 14 sltr embryos, long after the wild-type
myoblasts have completed fusion (Figures 6C and 6C0),
and further accumulate to large numbers in late stage 14
embryos (Figure 6D). These vesicles eventually disappear
from the mutant myoblasts (data not shown). The pro-
longed accumulation of vesicles suggests that besides
mistargeting, these vesiclesmight also be defective in fus-
ing to the plasma membrane in sltr mutant myoblasts.
To further investigate whether the fusion process is
completely blocked at the vesicle-plasma membrane fu-
sion stage or whether it could proceed beyond this point
in sltr mutant embryos, we looked for the presence, or
absence, of electron-dense plaques and membrane
discontinuities (fusion pores) along the apposing mem-
branes between founder and fusion-competent cells. No
electron-dense plaques were observed in sltrmutant em-
bryos, though such plaques are rarely seen in wild-type
embryos as well (Doberstein et al., 1997). To our surprise,
membrane discontinuities (R40 nm in diameter) were ob-Develoserved in sltr mutant embryos prepared by the conven-
tional chemical fixation method (data not shown). This re-
sult does not agree with that of the GFP diffusion assay
(Figures 1N–1N00), which indicates the absence of any
membrane openings R3.2 nm in diameter between the
founder and the fusion-competent cells. Because conven-
tional EM using chemical fixation is known to generate
‘‘fixation artifacts’’ due to slow diffusion of fixatives into
cells, we used the high-pressure freezing (HPF) method
(McDonald and Auer, 2006), which allows better preserva-
tion of cells with ultrarapid freezing of cellular structures,
to visualize the plasma membrane between apposing
myoblasts. As shown in Figure S5, and in agreement
with the GFP diffusion assay, the cell membrane between
founder and fusion-competent cells remains completely
intact in late stage 14 sltr embryos prepared using the
HPF method. We conclude that myoblast fusion is
blocked prior to the vesicle-plasma membrane fusion
stage in sltr mutant embryos.
WIP and WASP Are Required for Myoblast Fusion
in Mouse C2C12 Cells
The requirement of Sltr and WASP for myoblast fusion in
Drosophila prompted us to ask whether their mammalian
counterparts are involved in a similar process. In mam-
mals, there are two WASP proteins (WASP and N-
WASP) and three WIP homologs (WIP, WIRE/WICH, and
CR16). While WASP and CR16 are mainly expressed in
the hematopoietic system and the brain, respectively, N-
WASP, WIP, and WIRE are widely expressed (reviewed
by Anton and Jones, 2006; Miki and Takenawa, 2003).
Previous studies in mouse myoblast culture C2C12 cells
revealed a function of N-WASP in myoblast migration (Ka-
wamura et al., 2004). However, its potential function in
myoblast fusion has not been reported. We explored this
possibility by RNA interference experiments. As shown
in Figure 7A, N-WASP, WIP, and WIRE are all expressed
in C2C12 cells. RNAi knockdown of WIP or N-WASP,
but not WIRE, significantly reduced fusion between myo-
blasts (Figures 7Ba–7Bd and 7C). These results suggest
that WIP and N-WASP are important for myoblast fusion,
though it is not clear at present which specific step(s) of
the fusion process WIP and N-WASP are involved in. An
actin-filament destabilizing agent, latrunculin A, also in-
hibited the fusion of C2C12 cells (Figures 7Be and 7C),
consistent with an involvement of the actin cytoskeleton
in C2C12 myoblast fusion.(F–F00) Prefusion vesicles (arrow) are associated with microtubules (arrowhead).
(G–H00) Immuno-EMwith a-actin antibody. Compared to conventional EM (A–F00), no lead staining was performed for immuno-EM. As a result, most of
the intracellular electron-dense structures revealed by conventional EM, including the Golgi, microtubules, and ribosomes, appear either very faint or
are not detectable by immuno-EM. The dark grains in the immuno-EM panels represent silver-enhanced gold particles conjugated to the secondary
antibody.
(G) An actin-positive patch is observed adjacent to the plasma membrane of a myoblast. A prefusion vesicle residing in the actin patch is coated with
gold particles (arrow; close-up view in [G00]). Note that even though the vesicle may look similar to the electron-dense vesicles visualized by conven-
tional EM, it is visualized differently such that its dark margin is due to a-actin staining instead of lead staining. Two vesicles outside of the actin patch
appear very faint without a-actin or lead staining (arrowhead; close-up view in [G00 0]).
(H) Vesicles that have reached the apposing membranes remain coated with actin. Note that the actin-positive patch adjacent to the plasma mem-
brane is nearly absent, with only a small amount of residual actin farther away from the membrane (dark grains) in (H) and (H0).
The scale bars represent 500 nm in all panels except for (E00), (F00), (G00), (G00 0), and (H00), where they represent 250 nm.pmental Cell 12, 571–586, April 2007 ª2007 Elsevier Inc. 581
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Function of Actin Cytoskeleton in Myoblast FusionFigure 7. Mouse WIP and WASP Are Involved in Myoblast Fusion
(A) Knockdown of N-WASP, WIP, and WIRE by siRNA in C2C12 cells monitored by RT-PCR (a) and western blot (b).
(B) siRNA-transfected or latrunculin A-treated C2C12 cells were allowed to differentiate and were stained with Hoechst 33342 (red) and a-MHC
(green) to visualize nuclei and differentiated myoblasts/myotubes, respectively. Note that knockdown of N-WASP (b) or WIP (c), or latrunculin A treat-
ment (e), partially blocks myoblast fusion (compared to [a]). Knockdown of WIRE has no effect (d).
(C) Quantitation of experiments in (B). The fusion index is calculated as the percentage of nuclei in fusedmyotubes out of the total number of nuclei for
each 203 field. Cells withR2 nuclei were counted as a fused myotube. Each bar represents the mean ± standard error of thirty 203 fields from three
independent experiments.DISCUSSION
Our characterization of Sltr provides a number of novel,
and somewhat unexpected, findings concerning the role
of the actin cytoskeleton in myoblast fusion. In contrast
to the widespread expression of WIP in mammals, Sltr is
specifically expressed in developing muscles and, more-
over, only in fusion-competent myoblasts. Such cell-
type specificity is unexpected, given that Sltr is the only
WIP homolog inDrosophila. As a positive regulator of actin
polymerization, Sltr is recruited to sites of fusion by the
fusion receptor Sns and is required for the formation of
F-actin-enriched foci at these sites. Our EM studies sug-
gest that these actin-rich foci may provide directionality
for the trafficking of prefusion vesicles, which are routed
to ectopic membrane sites in the fusion-competent cells
in sltrmutant embryos.We suggest that targeted exocyto-
sis of prefusion vesicles represents a critical step leading
to plasma membrane fusion.
Sltr Mediates Signaling from the Fusion Receptor
to the Actin Cytoskeleton in Fusion-Competent Cells
The identification of Ants/Rols7 as a founder cell-specific
protein that mediates signaling from the fusion receptor
Duf to the actin cytoskeleton (Chen and Olson, 2001; Me-
non and Chia, 2001; Rau et al., 2001) suggests the exis-
tence of a fusion-competent cell-specific protein(s) with
an analogous function. Our current work suggests that
Sltr represents such a molecule. Not only is Sltr recruited
to sites of fusion by the fusion-competent cell-specific re-
ceptor Sns, likely mediated by the small adaptor protein
Crk, it also brings the actin polymerization machinery to
these sites by binding to WASP and G-actin. As a result,582 Developmental Cell 12, 571–586, April 2007 ª2007 ElsevierSltr colocalizes with F-actin-rich foci at sites of fusion,
and is required for the formation of these actin foci in
fusion-competent cells. Thus, like Ants/Rols7 in founder
cells, Sltr is a fusion-competent cell-specific protein that
links the fusion receptor with the actin cytoskeleton
(Figure 8A).
How does Sltr regulate actin polymerization? Our
in vitro and in vivo assays demonstrate that this activity
is mediated by the WH2 and WBD domains of Sltr, which
bind to actin and WASP, respectively. In Drosophila S2
cells, overexpression of Sltr, but not mutant forms lacking
the WH2 or WBD domains, leads to profound changes in
actin cytoskeleton organization characterized by the for-
mation of F-actin-filled microspikes. Likewise, the ability
of Sltr to rescue sltr mutant embryos requires the WH2
and WBD domains. These observations suggest that
both actin and WASP binding contribute to Sltr function.
Interestingly, while the first WH2 domain of Sltr binds to
G-actin, the second WH2 domain and its flanking region
interact with F-actin. Thus, the actin-binding activity of
Sltr serves a dual role—it not only provides a pool of mo-
nomeric G-actin (in addition to the G-actin recruited by
WASP) at sites of fusion but also stabilizes the newly
formed actin filaments. The importance of the WASP-
binding activity in Sltr function is further supported by
the observation that RNAi knockdown of WASP abolished
the ability of Sltr to inducemicrospikes in S2 cells, and that
WASP itself is required for myoblast fusion in Drosophila.
How WASP activity is regulated in myoblast fusion re-
mains to be determined. Although mammalian WASP is
known to be activated by the small GTPase Cdc42, this
is unlikely the case in Drosophila myoblast fusion, as ex-
pression of a dominant-negative Cdc42 does not causeInc.
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Function of Actin Cytoskeleton in Myoblast FusionFigure 8. Signal Transduction and the Function of the Actin Cytoskeleton during Myoblast Fusion
(A) A model for signal transduction in fusion-competent cells. We propose that in fusion-competent cells, Sltr is recruited to sites of fusion by Sns,
potentially mediated by the adaptor protein Crk. Localization of Sltr to sites of fusion in turn recruits monomeric G-actin (blue balls) and its binding
partnerWASP, which leads to localized induction of actin polymerization at sites of fusion. The Sns/Crk/Sltr/WASPpathway is likely parallel to
the Mbc/ Rac/ WAVE pathway that may be involved in fusion-competent cell migration and filopodia formation. Note that the involvement of
WAVE or Arp2/3 in myoblast fusion is inferred from their relationship with known signaling components.
(B) A model for the function of the actin cytoskeleton in myoblast fusion. A close-up view of the boxed area is shown on the right.
(a) Following myoblast adhesion, the fusion receptors Sns and Duf (not shown in the schematic) recruit the actin polymerization machinery to sites of
fusion. This recruitment is mediated by Sltr (green dots) in the fusion-competent cell and Sltr’s counterpart, for example, Ants (blue dots), in the
founder cell. Actin filaments are shown in red.
(b) Golgi-derived prefusion vesicles move to the cell periphery on microtubules. The F-actin foci at sites of fusion provide directionality for prefusion
vesicle trafficking. While passing through the actin-rich foci, prefusion vesicles become coated with actin (red circle on the vesicle).
(c) Prefusion vesicles remain actin coated after reaching the plasma membrane and the actin-rich foci disintegrate.
(d) Once prefusion vesicles release their contents—a fusogen or proteins/chemicals that stimulate a fusogenic activity—plasma membrane fusion is
triggered, leading to the formation of a multinucleated syncytium.any fusion defects (Luo et al., 1994). Future experiments
are required to identify the specific WASP activating fac-
tor(s) in myoblast fusion.
The Role of the Actin Cytoskeleton in Myoblast
Fusion
Myoblast fusion is a multistep process that includes cell
recognition, adhesion, alignment, and membrane merger.
To initiate the fusion process, fusion-competent cells that
reside in a deepermesodermal layer in the embryo need to
migrate and extend filopodia toward founder cells that are
in close contact with the ectoderm. Because the actin cy-
toskeleton is required for both cell migration and filopodia
formation (Etienne-Manneville and Hall, 2002), one may
predict that the actin cytoskeleton plays a role in these
early events of myoblast fusion. Indeed, mutations in
mbc and rac, components of the Mbc/ Rac/ WAVE
pathway, produce a large number of round-shaped fu-
sion-competent cells (Hakeda-Suzuki et al., 2002; Rush-
ton et al., 1995), suggesting a potential defect in myoblast
migration and/or filopodia formation.DeveloWhat we have identified in this study is a novel function
of the actin cytoskeleton in a later step during myoblast
fusion. This function is mediated by the Crk / Sltr /
WASP pathway, which is independent of that of Mbc/
Rac/WAVE, as the recruitment of Sltr by the fusion re-
ceptor Sns is not affected by either mbc or rac (Figures
2N and 2O). Using light microscopy, we have observed
F-actin-rich foci localized to sites of fusion during myo-
blast adhesion, raising the possibility that localized actin
polymerization at these sites may be functionally impor-
tant for fusion. We also demonstrate that the F-actin-rich
foci are organized by the fusion receptor and actin cyto-
skeleton regulators, as they are absent in sns and sltrmu-
tant fusion-competent cells. Taken together, these obser-
vations suggest a potential link between the fusion
receptor, actin polymerization, and the membrane fusion
machinery.
Our EM studies provide further insights into how local-
ized actin polymerization may contribute to myoblast fu-
sion by uncovering a relationship between the actin-rich
foci and prefusion vesicles. We found that the prefusion
vesicles are of exocytic origin and are transported to thepmental Cell 12, 571–586, April 2007 ª2007 Elsevier Inc. 583
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Function of Actin Cytoskeleton in Myoblast Fusionplasma membrane via the microtubule network (Figures
6E–6F00; Figures S4A–S4B0). Our immuno-EM analyses
further revealed two classes of vesicles, one coated with
and the other devoid of actin, at different subcellular loca-
tions (Figures 6G00, 6G00 0, and 6H00). While naked vesicles
are farther away from the actin foci, actin-coated vesicles
are either within the foci or have reached the plasmamem-
brane (Figures 6G–6H00; Figures S4C–S4D0). That all vesi-
cles at the membrane are actin-coated suggests that
they have transited through actin foci and thus become
distinct from the naked vesicles. Although we did not fol-
low the trafficking of these vesicles in real time due to the
lack of vesicle-specific markers, the ‘‘snapshots’’ pro-
vided by theEManalyses aremost consistentwith amodel
that actin foci at sites of fusion provide cortical capturing
sites for the prefusion vesicles (Figure 8B). This model is
further supported by the transient nature of the actin-
rich foci, which disintegrate in the cortical region after
the prefusion vesicles have paired along the membrane
in mature myoblasts. We believe that this model provides
a plausible explanation for the mistargeting of vesicles in
sltr mutant embryos—in the absence of actin foci at the
prospective fusion sites, prefusion vesicles are randomly
routed to the plasma membrane, resulting in their
accumulation between adjacent founder and fusion-
competent cells as well as between neighboring fusion-
competent cells.
It is intriguing that in mature myoblasts, the prefusion
vesicles that have aligned at the plasma membrane are
all actin-coated, concurrent with an absence of the ac-
tin-rich patches at the cell cortex. Could actin coating of
the prefusion vesicles, as well as disintegration of the ac-
tin-rich foci in mature myoblasts, play a role in vesicle-
membrane fusion? The failure of vesicle-plasma mem-
brane fusion in sltr mutant myoblasts with either too little
(in fusion-competent cells) or prolonged accumulation of
(in founder cells) actin is consistent with this possibility.
While definitive answers to these questions await future
investigation, it is worth noting that actin is required for
yeast vacuole fusion (Eitzen et al., 2002) and that actin
has recently been identified as a component of neuronal
synaptic vesicles (Takamori et al., 2006).
An important future direction is to identify the biochem-
ical composition of theprefusion vesicles. The involvement
of such vesicles in myoblast fusion is not unique to Dro-
sophila, as similar vesicles with electron-dense material
have been reported in quail myoblast cultures (Lipton
and Konigsberg, 1972) and the L6 rat muscle cells (Engel
et al., 1985). It is conceivable that these vesicles may de-
liver an unknown fusogen, or proteins/chemicals that stim-
ulate fusogen activity, to the fusion sites, which ultimately
leads to the fusion of apposing cell membranes. Because
the actin cytoskeleton has also been implicated in other
types of cell-cell fusion events, including fusion of human
macrophages (DeFife et al., 1999) and viral-induced cell-
cell fusion (Pontowet al., 2004), we speculate that targeted
exocytosis of prefusion vesicles might represent a general
step in myoblast fusion from Drosophila to mammals and
perhaps in other cell-cell fusion events as well.584 Developmental Cell 12, 571–586, April 2007 ª2007 ElsevierEXPERIMENTAL PROCEDURES
Fly Genetics
The sltrS1946 mutant allele was isolated in a genetic screen for muscle
development (E.H.C., unpublished data). Other fly stocks were ob-
tained from the Bloomington Stock Center except the following: lmd/
TM3, ftz-lacZ (H. Nguyen); rac1rac2/TM3 and UAS-CD8GFP (L. Luo);
sns40-49/CyO (R. Renkowitz-Pol); FRT82B, Wasp3, e/TM6B (A. Zelhof
and E. Schejter); rP298-lacZ (A. Nose); and rP298-GAL4 (D. Menon).
Rescue crosses were performed by crossing Twi-GAL4, sltr/CyO,
actin-lacZ with UAS-sltr, sltr/CyO, actin-lacZ or UAS-‘‘sltr mutant,’’
sltr/CyO, actin-lacZ, in which ‘‘sltr mutant’’ represents sltrDWH2-
1&2, sltrDWH2-1, sltrK49Q, sltrDWH2-2, or sltrDWBD.Wasp germline
clones were generated using the FLP/FRT system as described (Chou
and Perrimon, 1996). For the GFP diffusion assay, rP298-GAL4;
sltrS1946/CyO males were crossed with sltrS1946, UAS-GFP/CyO
females. Mutant embryos were identified with a-Kr staining.
Immunohistochemistry
Antibody staining is described in the Supplemental Data. For staining
of F-actin, embryos were fixed and hand devitellinized, followed by in-
cubation with FITC-conjugated phalloidin (1 mg/ml) (Sigma) for 1 hr at
room temperature.
For cell staining, S2 cells and differentiated C2C12 cultures were
fixed with 4% paraformaldehyde, washed, and stained with the follow-
ing: mouse a-V5 (1:1000) (Invitrogen), Cy3-conjugated phalloidin (40
nm) (Molecular Probes), and mouse a-skeletal myosin (MY32) (1:200)
(Sigma). Nuclei were visualized by staining with Hoechst 33342 (Invi-
trogen). Secondary FITC-conjugated antibodies were used at 1:200
(Jackson).
Molecular Biology
Themolecular lesion of the sltrS1946 allele was determined by sequenc-
ing genomic DNA amplified from homozygous mutant embryos, iden-
tified by the lack of GFP expression present on the balancer chromo-
some. Full-length EST clones of sltr, Wasp, and Crk were obtained
from the Drosophila Genomics Resource Center.
Constructs for S2 cell transfection, GST pull-down, and phenotypic
rescue, as well as RT-PCR analyses forWASP,WIP, andWIRE expres-
sion in C2C12 cells, are described in the Supplemental Data.
Biochemistry
GST-Sltr and GST-Crk were expressed and purified according to stan-
dard protocols (Pharmacia). For GST pull-down assays, glutathione-
Sepharose beads (Amersham) were mixed with an equal volume of
GST fusion proteins at a concentration of approximately 3 mg/ml beads.
Beads with immobilized proteins were used to pull down G-actin or
target proteins from cell lysates.
Detailed procedures for G-actin binding, F-actin cosedimentation,
immunoprecipitation, and GST pull-down are described in the Supple-
mental Data.
Cell Culture and Transfection
S2 or S2R+ cells were grown in Drosophila serum-free medium or
Schneider’s Drosophila medium containing 10% fetal bovine serum
(FBS), respectively. Cells were transfected using Effectene (Qiagen)
according to the manufacturer’s instructions.
Mouse C2C12 cells (ATCC) were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) containing 20% FBS. Differentiation was in-
duced at 70% confluency on plates previously coated with 0.1% gel-
atin by replacing growth media with differentiation media containing
DMEM, 2% heat-inactivated horse serum, 10 mg/ml insulin, and
10 mg/ml transferrin (Invitrogen), and analyzed 2 days after induction.
RNA Interference in C2C12 Cells
See the Supplemental Data.Inc.
Developmental Cell
Function of Actin Cytoskeleton in Myoblast FusionTransmission Electron Microscopy
EM analysis was carried as described by Doberstein et al. (1997).
Briefly, embryos were fixed in heptane that had been previously equil-
ibrated with 25% glutaraldehyde/10% acrolein in 0.1 M sodium-caco-
dylate buffer (pH 7.4). Postfixation with osmium tetroxide and negative
staining with 1% uranyl acetate were performed before embedding
with EPON (Sigma). Lead staining was done according to Sato
(1968) to improve image analysis. Images were acquired on a Philips
CM 120 transmission electron microscope.
Immuno-EM
Immuno-EM was carried out as previously described (Tepass, 1996).
Briefly, embryos were prefixed for 30 min in a 1:1 mixture of fixation
buffer (8% paraformaldehyde and 0.02% glutaraldehyde in 0.1 M so-
dium phosphate buffer [pH 7.2]) and heptane under vigorous shaking.
After hand devitellinization, the anterior 20% of the embryos was cut
off to allow antibody access to the interior of the embryo. The embryos
were thenwashed for 15min in PBS containing 1%normal goat serum,
50 mM glycine, 1 mg/ml BSA, 0.02% sodium azide, and 0.01% sapo-
nin, followed by incubation with a-actin mAb (1:100) (clone AC-40;
Sigma) for 2 hr at room temperature. Embryos were then incubated
with Nanogold a-mouse Fab0 (1:200) (Nanoprobes) for 2 hr, followed
by postfixation and silver enhancement. Dehydration, embedding,
and sectioning were done as described in transmission electron mi-
croscopy, with the exception that no lead staining was performed in
order to keep an overall low background.
Supplemental Data
Supplemental Data include five figures, Supplemental Experimen-
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